[Contribution of various MRI techniques to the characterization of Mild cognitive impairment]
- PMID: 20215099
- DOI: 10.1684/pnv.2010.0200
[Contribution of various MRI techniques to the characterization of Mild cognitive impairment]
Abstract
Mild cognitive impairment (MCI) is considered as a strong risk factor for Alzheimer's disease (AD) or other dementia syndromes. Since the last decade, numerous publications have been aimed to characterize early detectable brain changes in vivo, using more and more efficient neuroimaging techniques. This review is devoted to the brain damages detectable in MCI patients according to the MRI techniques available to date. The greatest number of studies, using structural and functional imaging, report many abnormalities principally located in the medial temporal lobe. They show, especially in this region, cortical atrophy, reduction of glucose metabolism, decrease in regional cerebral blood flew and biochemical changes. Moreover, progresses in the functional methods allow to detect brain activity during memory tasks, trying to specify whether this activity increases or decreases according to the task and the severity of cognitive impairment. The contribution of each RMI technique (morphologic, metabolic, and functional) is addressed in order to reveal how relevant they are to distinguish subjects with MCI from patients with early AD. Furthermore, their relevance to discriminate between MCI with different degrees of cognitive deficit and their power to predict the risk of conversion to AD is discussed. Finally, we review the main assumptions made to explain the underlying mechanisms of cognitive decline and present evidences in favor of dynamic compensatory processes, existence of cognitive reserve and disconnection processes. Many neuroimaging data support the pattern of installation and evolution of brain damages found in AD, reinforcing the idea that a part of amnesic MCI is probably a prodromal state of AD.
Similar articles
-
MRI and CSF studies in the early diagnosis of Alzheimer's disease.J Intern Med. 2004 Sep;256(3):205-23. doi: 10.1111/j.1365-2796.2004.01381.x. J Intern Med. 2004. PMID: 15324364
-
Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.Arch Neurol. 2008 Jan;65(1):94-100. doi: 10.1001/archneurol.2007.23. Arch Neurol. 2008. PMID: 18195145
-
A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.Neuroimage. 2005 Jul 15;26(4):1159-63. doi: 10.1016/j.neuroimage.2005.03.005. Neuroimage. 2005. PMID: 15878675
-
[Neuroimaging in Alzheimer's disease: an overview].Rev Neurol. 2004 Jun 16-30;38(12):1156-65. Rev Neurol. 2004. PMID: 15229831 Review. Spanish.
-
Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.Clin Ther. 2006 Jul;28(7):991-1001. doi: 10.1016/j.clinthera.2006.07.006. Clin Ther. 2006. PMID: 16990077 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical